0R0O Stock Chart & Stats
$422.03
$4.21(1.00%)
At close: 4:00 PM EDT
$422.03
$4.21(1.00%)
Day’s Range― - ―
52-Week Range$254.75 - $461.00
Previous CloseN/A
Volume5.15K
Average Volume (3M)3.67K
Market Cap
$338.03B
Enterprise Value$457.39K
Total Cash (Recent Filing)$31.47B
Total Debt (Recent Filing)$73.33B
Price to Earnings (P/E)24.3
Beta0.32
Next Earnings
Oct 13, 2026EPS Estimate
4.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)15.55
Shares Outstanding897,594,850
10 Day Avg. Volume2,754
30 Day Avg. Volume3,672
Financial Highlights & Ratios
PEG Ratio-1.62
Price to Book (P/B)3.19
Price to Sales (P/S)0.67
P/FCF Ratio18.69
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$481.58Price Target Upside14.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering22
EPS Forecast (FY)19.81
Revenue Forecast (FY)$445.72B
Bulls Say, Bears Say
Bulls Say
Durable Revenue GrowthTTM revenue growth of about 9% and a multi-year growth record show that UNH continues to expand its top line across insurance and health-services activities. This scale can support broader customer reach and operating leverage over the next several quarters.
Strong Cash GenerationTTM operating cash flow of about $27.0B and free cash flow of about $23.6B, with 85% conversion from net income, indicate substantial internal funding capacity. That cash can support investment, dividends, repurchases and resilience while operations scale.
Optum Platform StrengthOptum’s broad presence across care delivery, pharmacy and technology gives UNH multiple positions in the healthcare value chain. Performance at or ahead of plan, combined with reach across about 90% of U.S. counties, supports durable customer access and cross-segment growth.
Bears Say
Margin CompressionThe sharp decline in net and EBIT margins versus 2022–2023 shows that revenue growth is not translating into prior levels of profitability. Persistently lower margins could constrain earnings growth, reduce operating flexibility and require continued cost-management efforts.
Medical Cost PressureElevated commercial medical costs and negative Medicaid margins create a broad profitability challenge across important insurance businesses. Pricing, reimbursement and cost actions may take time to catch up, keeping margin recovery uncertain and limiting earnings visibility over coming quarters.
Medicare Advantage Enrollment DeclineA projected decline of about 1.1 million Medicare Advantage members is a meaningful headwind to membership scale and premium growth. Even with expected Medicare margins above 3%, fewer members can reduce revenue leverage and weaken the business’s competitive momentum.
UnitedHealth News
0R0O FAQ
What was UnitedHealth’s price range in the past 12 months?
UnitedHealth lowest share price was $254.75 and its highest was $461.00 in the past 12 months.
What is UnitedHealth’s market cap?
UnitedHealth’s market cap is $338.03B.
When is UnitedHealth’s upcoming earnings report date?
UnitedHealth’s upcoming earnings report date is Oct 13, 2026 which is in 14 days.
How were UnitedHealth’s earnings last quarter?
UnitedHealth released its earnings results on Jul 16, 2026. The company reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.907 by $1.473.
Is UnitedHealth overvalued?
According to Wall Street analysts UnitedHealth’s price is currently Undervalued.
Does UnitedHealth pay dividends?
UnitedHealth does not currently pay dividends.
What is UnitedHealth’s EPS estimate?
UnitedHealth’s EPS estimate is 4.12.
How many shares outstanding does UnitedHealth have?
UnitedHealth has 897,594,850 shares outstanding.
What happened to UnitedHealth’s price movement after its last earnings report?
UnitedHealth reported an EPS of $6.38 in its last earnings report, beating expectations of $4.907. Following the earnings report the stock price went up 2.069%.
Which hedge fund is a major shareholder of UnitedHealth?
Currently, no hedge funds are holding shares in GB:0R0O
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UnitedHealth Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$481.58 (14.11% Upside)
$481.58 (14.11% Upside)
Blogger Sentiment
Bullish
GB:0R0O Sentiment 88%
Sector Average 64%
Sector Average 64%
Insider Transactions
Sold Shares
Worth $660.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.88%
12-Months-Change
Fundamentals
Return on Equity
2.41%
Trailing 12-Months
Asset Growth
0.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
UnitedHealth
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
0R0O Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a broadly positive tone: strong quarter-to-date financial results (notably double-digit EPS growth and raised guidance), solid operational progress across Optum (AI-led efficiency gains, improved care metrics), and meaningful shareholder returns and balance sheet improvement. However, the company faces notable near-term headwinds—elevated commercial medical cost trends, pressured Medicaid margins, Medicare enrollment declines, and some one-time favorable prior-period development—creating areas of ongoing focus and uncertainty. On balance, the positive developments and upgraded outlook outweigh the challenges, but management emphasizes continued urgency and investment to sustain improvement.View all GB:0R0O earnings summaries0R0O Revenue Breakdown
78.70% Premiums
11.93% Products
8.50% Services
0.88% Investment and other income
0R0O Stock 12 Month Forecast
Average Price Target
$481.58
▲(14.11% Upside)